Curated News
By: NewsRamp Editorial Staff
October 23, 2025
Quantum BioPharma's Unbuzzd Hosts Investor Webinar for $5M Raise
TLDR
- Quantum BioPharma's licensee Unbuzzd Wellness is raising up to $5 million with no dilution to Quantum shareholders, offering investors early access to a scientifically proven alcohol metabolism beverage.
- Unbuzzd Wellness will host an investor webinar on October 30, 2025, featuring leadership discussing the investment opportunity, strategy, distribution plans, and Q&A for their alcohol metabolism beverage.
- Unbuzzd's scientifically proven beverage accelerates alcohol metabolism and reduces hangover symptoms, potentially improving public health outcomes related to alcohol consumption.
- The unbuzzd beverage features former Celsius CEO Gerry David on its board and is backed by Quantum BioPharma's research in neurodegenerative and metabolic disorders.
Impact - Why it Matters
This development represents a significant advancement in consumer health technology that could transform how people manage alcohol consumption and its aftereffects. The scientifically proven unbuzzd(TM) beverage addresses a widespread global concern affecting millions of people who consume alcohol socially or regularly. Beyond the immediate consumer benefits of reduced hangover symptoms and restored mental clarity, the technology represents a novel approach to alcohol metabolism that could have broader implications for public health and safety. For investors, the non-dilutive financing structure protects existing Quantum BioPharma shareholders while providing capital to accelerate market penetration of a product with substantial commercial potential in the multi-billion dollar wellness and beverage industries.
Summary
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company advancing treatments for neurodegenerative, metabolic, and alcohol misuse disorders, has announced that its licensee Unbuzzd Wellness Inc. will host a significant investor webinar on October 30, 2025, at 4:15 p.m. ET. This event serves as part of Unbuzzd's Reg D 506(c) offering and up to $5 million capital raise, with the notable provision that this financing creates no dilution to Quantum BioPharma shareholders. The webinar will feature prominent industry leaders including Unbuzzd CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David, who previously served as CEO of Celsius Holdings.
The investor presentation will focus on the investment opportunity surrounding unbuzzd(TM), a scientifically proven beverage that accelerates alcohol metabolism, restores mental clarity, and reduces hangover symptoms. Participants will gain insights into Unbuzzd's leadership strategy, distribution plans, and have the opportunity to engage in a Q&A session with the executive team. Quantum BioPharma originally invented the unbuzzd(TM) formula and spun out its over-the-counter version to Unbuzzd Wellness Inc., which is now led by experienced industry veterans. The company maintains a significant 20.11% ownership stake in Unbuzzd Wellness Inc. as of March 31, 2025, and stands to benefit from royalty payments of 7% of sales until payments total $250 million, after which the royalty decreases to 3% in perpetuity.
Beyond its involvement with Unbuzzd, Quantum BioPharma continues to advance its core biopharmaceutical pipeline through its wholly owned subsidiary Lucid Psycheceuticals Inc. The company's lead compound, Lucid-MS, represents a patented new chemical entity shown to prevent and reverse myelin degradation—the underlying mechanism of multiple sclerosis—in preclinical models. Quantum BioPharma retains full rights to develop similar products or alternative formulations specifically for pharmaceutical and medical applications, positioning the company to capitalize on both consumer wellness and medical treatment markets. Additional information about the company and this announcement can be found through the BioMedWire platform, which provides specialized communications services for the biotechnology and life sciences sectors.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Quantum BioPharma's Unbuzzd Hosts Investor Webinar for $5M Raise
